ASA clears Nurofen of misleading TV ad
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Reckitt Benckiser’s (RB’s) UK television advertisement for Nurofen did not misleadingly imply that the product specifically targeted headache pain, the country’s Advertising Standards Authority (ASA) has ruled.
You may also be interested in...
ASA Clears RB Of Misleading UK Consumers In Two Nurofen Ads
The UK's Advertising Standards Authority has cleared Reckitt Benckiser of misleading British consumers with two advertisements for its Nurofen brand of analgesics.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.